← Back to Patent Explorer
US4873235A Expired / Lapsed US ⏱️ 0.0 years remaining

Benzofused lactams as antihypertensives

Assignee: Merck and Co Inc
•
Filing: 1983-03-16
•
Granted: 1989-10-10
•
Expires: 2003-03-16
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Benzofused lactams of the formula: <IMAGE> and their use as angiotensin converting enzyme inhibitors and antihypertensive agents are disclosed.

Inventors

  • 👤 William H. Parsons
  • 👤 Arthur A. Patchett
  • 👤 Eugene D. Thorsett

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 21:33
CPC Classifications
C; C07; C07K; C07K5/00; C07K5/02; C07K5/022; C07K5/0222; A; A61; A61K; A61K38/00

Claims Analysis

Total Claims: 22
Claim 1
Independent Claim 638 words
A compound having the formula: ##STR55## and pharmaceutically acceptable salts thereof wherein n is R 4 is hydrogen, lower alkyl, phenyl, phenyl lower alkyl, hydroxy phenyl lower alkyl, hydroxy lower alkyl, amino lower alkyl, acylamino lower alkyl, guanidino lower alkyl, imidazolyl lower alkyl, indolyl lower alkyl, mercapto lower alkyl or lower alkyl thio lower alkyl; R 2 is hydrogen, R 3 is H, halo, lower alkyl, cycloalkyl, or loweralkoxy, R 1 is hydrogen; hydrocarbon of from 1 to 12 carbon atoms which include branched and unsaturated alkyl groups; cycloalkyl; substituted loweralkyl wherein the substituent can be halo, hydroxy, carboxy, carboxamido, loweralkylthio, loweralkoxy, loweralkoxycarbonyl, loweraralkoxycarbonyl, amino, loweralkylamino, lowerdialkylamino, acylamino; substituted loweralkylamino wherein the substituent can be halo, hydroxy, alkoxy or cyano; arloweralkylamino; cyclic amino; oxo, thio or ureido; aryloxy; arylthio; aralkyloxy; aralkylthio; benzofused cycloalkyl or bicycloalkyl of from 8-12 carbon atoms; aryl or heteroaryl which may be mono-, di- or trisubstituted by loweralkyl, hydroxy, loweralkoxy, halo, amino, acylamino, loweralkylthio or aminoloweralkyl; benzofused cycloalkyl or bicycloalkyl of from 8 to 12 carbon atoms; arloweralkyl; arloweralkenyl; heteroloweralkyl and heteroloweralkenyl in which the aryl or heteroaryl rings may be mono-, di- or tri-substituted by halo, loweralkyl, hydroxy, loweralkoxy, amino, loweralkylamino, diloweralkylamino, aminoloweralkyl, acylamino, carboxy, haloloweralkyl, nitro, cyano or sulfonamido; aralkyl or heteroaralkyl which include branched loweralkyl groups; substituted aralkyl or substituted heteroaralkyl which include branched loweralkyl groups wherein the loweralkyl groups can be substituted by amino, acylamino, or hydroxyl and the aryl and heteroaryl groups can be substituted by halo, dihalo, loweralkyl, hydroxy, loweralkoxy, aryloxy, aroyl, arylthio, amino, aminoloweralkyl, loweralkanoylamino, aroylamino, lowerdialkylamino, loweralkylamino, hydroxy, hydroxyloweralkyl, trihaloloweralkyl, nitro, cyano, or sulfonamido; any of the arloweralkyl or alkenyl and heteroloweralkyl or alkenyl groups described above in which the aryl or heteroaryl ring is partially or completely hydrogenated; substituted loweralkyl having the formula R A 1 (CH 2 ) n --Q--(CH 2 ) m wherein n is 0-2, m is 1-3, R A 1 is aryl or heteroaryl optionally substituted by amino, lowerdialkylamino, loweralkylamino, hydroxy, hydroxyloweralkyl, aminoloweralkyl, trihaloloweralkyl, cyano, nitro, sulfonamido, aroyl, loweralkyl, halo, dihalo, and loweralkoxy, and Q is O, S, SO, SO 2 , N-R B 1 , CONR C 1 , NR C 1 CO, CH═CH wherein R B 1 is hydrogen, loweralkyl, aryl, aralkyl, loweralkanoyl, or aroyl, and R C 1 is hydrogen, or loweralkyl; R 5 and R 6 are independently selected from H, lower alkyl, lower alkenyl, diloweralkylamino, loweralkyl, substituted lower alkyl wherein the substituents are monohydroxy, dihydroxy or acylamino; acylloweralkyl and arloweralkyl; and, the pharmaceutically acceptable salts thereof, wherein in said R 1- R 6 groups, unless stated otherwise, the alkyl substituents denote straight and branched chain hydrocarbons of C 1 -C 12 ; loweralkyl denotes alkyl groups of C 1 to C 8 ; alkenyl and alkynyl denote alkyl groups as defined above which are modified so that each contains a carbon to carbon double bond or triple bond, respectively; cycloalkyl denotes rings composed of 5 to 8 methylene groups, each which may be substituted or unsubstituted with other hydrocarbon substituents; benzofused cycloalkyl groups denote a cycloalkyl ring of 5 to 8 carbon atoms to which is fused a benzene ring; bicycloalkyl denotes two cycloalkyl rings of 5 to 8 carbon atoms each joined together in any allowable way; loweralkoxy substituents denote a loweralkyl group as described above attached through an oxygen bridge; the aralkyl and heteroaralkyl substituents denote aryl or heteroaryl groups as herein defined attached through a straight or branched chain hydrocarbon of from one to six carbon atoms; aryl represents phenyl, naphthyl, or biphenyl; heteroaryl represents any 5- or 6-membered aromatic ring containing from one to three heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur as well as any bicyclic group in which any of the above heterocyclic rings is fused to another aromatic ring; and acylamino represents loweralkanoylamino and aroylamino.
Claim 2
Dependent Claim 638 words
A compound having the formula: ##STR55## and pharmaceutically acceptable salts thereof wherein n is R 4 is hydrogen, lower alkyl, phenyl, phenyl lower alkyl, hydroxy phenyl lower alkyl, hydroxy lower alkyl, amino lower alkyl, acylamino lower alkyl, guanidino lower alkyl, imidazolyl lower alkyl, indolyl lower alkyl, mercapto lower alkyl or lower alkyl thio lower alkyl; R 2 is hydrogen, R 3 is H, halo, lower alkyl, cycloalkyl, or loweralkoxy, R 1 is hydrogen; hydrocarbon of from 1 to 12 carbon atoms which include branched and unsaturated alkyl groups; cycloalkyl; substituted loweralkyl wherein the substituent can be halo, hydroxy, carboxy, carboxamido, loweralkylthio, loweralkoxy, loweralkoxycarbonyl, loweraralkoxycarbonyl, amino, loweralkylamino, lowerdialkylamino, acylamino; substituted loweralkylamino wherein the substituent can be halo, hydroxy, alkoxy or cyano; arloweralkylamino; cyclic amino; oxo, thio or ureido; aryloxy; arylthio; aralkyloxy; aralkylthio; benzofused cycloalkyl or bicycloalkyl of from 8-12 carbon atoms; aryl or heteroaryl which may be mono-, di- or trisubstituted by loweralkyl, hydroxy, loweralkoxy, halo, amino, acylamino, loweralkylthio or aminoloweralkyl; benzofused cycloalkyl or bicycloalkyl of from 8 to 12 carbon atoms; arloweralkyl; arloweralkenyl; heteroloweralkyl and heteroloweralkenyl in which the aryl or heteroaryl rings may be mono-, di- or tri-substituted by halo, loweralkyl, hydroxy, loweralkoxy, amino, loweralkylamino, diloweralkylamino, aminoloweralkyl, acylamino, carboxy, haloloweralkyl, nitro, cyano or sulfonamido; aralkyl or heteroaralkyl which include branched loweralkyl groups; substituted aralkyl or substituted heteroaralkyl which include branched loweralkyl groups wherein the loweralkyl groups can be substituted by amino, acylamino, or hydroxyl and the aryl and heteroaryl groups can be substituted by halo, dihalo, loweralkyl, hydroxy, loweralkoxy, aryloxy, aroyl, arylthio, amino, aminoloweralkyl, loweralkanoylamino, aroylamino, lowerdialkylamino, loweralkylamino, hydroxy, hydroxyloweralkyl, trihaloloweralkyl, nitro, cyano, or sulfonamido; any of the arloweralkyl or alkenyl and heteroloweralkyl or alkenyl groups described above in which the aryl or heteroaryl ring is partially or completely hydrogenated; substituted loweralkyl having the formula R A 1 (CH 2 ) n --Q--(CH 2 ) m wherein n is 0-2, m is 1-3, R A 1 is aryl or heteroaryl optionally substituted by amino, lowerdialkylamino, loweralkylamino, hydroxy, hydroxyloweralkyl, aminoloweralkyl, trihaloloweralkyl, cyano, nitro, sulfonamido, aroyl, loweralkyl, halo, dihalo, and loweralkoxy, and Q is O, S, SO, SO 2 , N-R B 1 , CONR C 1 , NR C 1 CO, CH═CH wherein R B 1 is hydrogen, loweralkyl, aryl, aralkyl, loweralkanoyl, or aroyl, and R C 1 is hydrogen, or loweralkyl; R 5 and R 6 are independently selected from H, lower alkyl, lower alkenyl, diloweralkylamino, loweralkyl, substituted lower alkyl wherein the substituents are monohydroxy, dihydroxy or acylamino; acylloweralkyl and arloweralkyl; and, the pharmaceutically acceptable salts thereof, wherein in said R 1- R 6 groups, unless stated otherwise, the alkyl substituents denote straight and branched chain hydrocarbons of C 1 -C 12 ; loweralkyl denotes alkyl groups of C 1 to C 8 ; alkenyl and alkynyl denote alkyl groups as defined above which are modified so that each contains a carbon to carbon double bond or triple bond, respectively; cycloalkyl denotes rings composed of 5 to 8 methylene groups, each which may be substituted or unsubstituted with other hydrocarbon substituents; benzofused cycloalkyl groups denote a cycloalkyl ring of 5 to 8 carbon atoms to which is fused a benzene ring; bicycloalkyl denotes two cycloalkyl rings of 5 to 8 carbon atoms each joined together in any allowable way; loweralkoxy substituents denote a loweralkyl group as described above attached through an oxygen bridge; the aralkyl and heteroaralkyl substituents denote aryl or heteroaryl groups as herein defined attached through a straight or branched chain hydrocarbon of from one to six carbon atoms; aryl represents phenyl, naphthyl, or biphenyl; heteroaryl represents any 5- or 6-membered aromatic ring containing from one to three heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur as well as any bicyclic group in which any of the above heterocyclic rings is fused to another aromatic ring; and acylamino represents loweralkanoylamino and aroylamino.
Claim 3
Dependent Claim 39 words
A compound of claim 1 wherein: R 1 is loweralkyl, phenyl lower alkyl or amino loweralkyl; R 3 is H; R 4 is H and R 5 and R 6 are independently selected from H, lower alkyl or arloweralkyl.
Claim 4
Dependent Claim 30 words
A compound of claim 5 wherein R 1 is phenylloweralkyl and R 5 and R 6 are independently selected from H, CH 3 , C 2 H 5 or benzyl.
Claim 5
Dependent Claim 10 words
A compound of claim 6 wherein R 1 is ##STR56##
Claim 6
Dependent Claim 23 words
A compound of claim 7 wherein R 5 is H, CH 3 or benzyl and R 6 is H, CH 3 or ethyl.
Claim 7
Dependent Claim 18 words
A compound of claim 7 wherein both R 5 and R 6 are H or CH 3 .
Claim 8
Dependent Claim 35 words
A pharmaceutical composition for effecting angiotensin converting enzyme inhibition or treating hypertension in humans comprising a pharmaceutically acceptable carrier; and, an angiotensin converting enzyme inhibitive or antihypertensively effective amount of a compound of claim 1.
Claim 9
Dependent Claim 91 words
The composition of claim 7 which includes another antihypertensive and/or diuretic selected from the group: amiloride, atenolol, benzofluoromethiazide, chlorothalidone, chlorothiazide, clonidine, cryptenamine acetate and cryptenamine tannates, deserpidine, diazoxide, guanethidene sulfate, hydralazine hydrochloride, hydrochlorothiazide, hydroflumethiazide, metolazone, metroprololtartate, methyclothiazide, methyldopa, methyldopate hydrochloride, minoxidil, (S)-1-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-3-{[4-(2-thienyl)-1H-imidazol-2-yl]phenoxy}-2-propanol, polythiazide, the pivaloyloxyethyl ester of methyldopa, indacrinone and variable ratios of its enantiomers, nifedipine, verapamil, diltiazam, fluoroethiazide, atenolol, (+)-4-{3-{-[2-(1-hydroxycyclohexyl)ethyl]-4-oxo-2-thiazolidinyl}propyl}benzoic acid, bumetanide, prazosin, propranolol, rauwolfia serpentina, rescinnamine, reserpine, spironolactone, timolol, trichlormethiazide, benzthiazide, quinethazone, tricrynafan, triamterene, acetazolamide, aminophylline, cyclothiazide, merethoxylline procaine, and the like, as well as admixtures and combinations thereof.
Claim 10
Dependent Claim 39 words
A method for effecting angiotensin converting enzyme inhibition or treating hypertension which comprises administering to a patient in need of such effectation or treatment an angiotensin converting enzyme inhibitive or antihypertensively effective amount of a compound of claim 1.
Claim 11
Dependent Claim 74 words
A process for preparing a compound of claim 1 which comprises coupling of a compound of the formula: ##STR57## with a compound of the formula: ##STR58## to obtain a compound of claim 1 wherein each of R 5 and R 6 is alkyl and subsequently hydrolyzing said compound having R 5 and R 6 alkyl to obtain a claim 1 compound where both R 5 and R 6 are H and n is 1.
Claim 12
Dependent Claim 639 words
A compound having the formula: ##STR59## and pharmaceutically acceptable salts thereof wherein n is 1; R 4 is hydrogen, lower alkyl, phenyl, phenyl lower alkyl, hydroxy phenyl lower alkyl, hydroxy lower alkyl, amino lower alkyl, acylamino lower alkyl, guanidino lower alkyl, imidazolyl lower alkyl, indolyl lower alkyl, mercapto lower alkyl or lower alkyl thio lower alkyl; R 2 is hydrogen, R 3 is H; halo, lower alkyl, cycloalkyl, or loweralkoxy, R 1 is hydrogen; alkyl of from 1 to 12 carbon atoms which include branched and unsaturated alkyl groups; cycloalkyl; substituted loweralkyl wherein the substituent can be halo, hydroxy, carboxy, carboxamido, loweralkylthio, loweralkoxy, loweralkoxycarbonyl, loweraralkoxycarbonyl, amino, loweralkylamino, lowerdialkylamino, acylamino; substituted loweralkylamino wherein the substituent can be halo, hydroxy, alkoxy or cyano; arloweralkylamino; cyclic amino; oxo, thio or ureido; aryloxy; arylthio; aralkyloxy; aralkylthio; benzofused cycloalkyl or bicycloalkyl of from 8-12 carbon atoms; aryl or heteroaryl which may be mono-, di- or trisubstituted by loweralkyl, hydroxy, loweralkoxy, halo, amino, acylamino, loweralkylthio or aminoloweralkyl; benzofused cycloalkyl or bicycloalkyl of from 8 to 12 carbon atoms; arloweralkyl; arloweralkenyl; heteroloweralkyl and heteroloweralkenyl in which the aryl or heteroaryl rings may be mono-, di- or tri-substituted by halo, loweralkyl, hydroxy, loweralkoxy, amino, loweralkylamino, diloweralkylamino, aminoloweralkyl, acylamino, carboxy, haloloweralkyl, nitro, cyano or sulfonamido; aralkyl or heteroaralkyl which include branched loweralkyl groups; substituted aralkyl or substituted heteroaralkyl which include branched loweralkyl groups wherein the loweralkyl groups can be substituted by amino, acylamino, or hydroxyl and the aryl and heteroaryl groups can be substituted by halo, dihalo, loweralkyl, hydroxy, loweralkoxy, aryloxy, aroyl, arylthio, amino, aminoloweralkyl, loweralkanoylamino, aroylamino, lowerdialkylamino, loweralkylamino, hydroxy, hydroxyloweralkyl, trihaloloweralkyl, nitro, cyano, or sulfonamido; any of the arloweralkyl or alkenyl and heteroloweralkyl or alkenyl groups described above in which the aryl or heteroaryl ring is partially or completely hydrogenated; substituted loweralkyl having the formula R A 1 (CH 2 ) n --Q--(CH 2 ) m wherein n is 0-2, m is 1-3, R A 1 is aryl or heteroaryl optionally substituted by amino, lowerdialkylamino, loweralkylamino, hydroxy, hydroxyloweralkyl, aminoloweralkyl, trihaloloweralkyl, cyano, nitro, sulfonamido, aroyl, loweralkyl, halo, dihalo, and loweralkoxy, and Q is O, S, SO, SO 2 , N-R B 1 , CONR C 1 , NR C 1 CO, CH═CH wherein R B 1 is hydrogen, loweralkyl, aryl, aralkyl, loweralkanoyl, or aroyl, and R C 1 is hydrogen, or loweralkyl; R 5 and R 6 are independently selected from H, lower alkyl, lower alkenyl, diloweralkylamino, loweralkyl, substituted lower alkyl wherein the substituents are monohydroxy, dihydroxy or acylamino; acylloweralkyl and arloweralkyl; and, the pharmaceutically acceptable salts thereof, wherein in said R 1 -R 6 groups, unless stated otherwise, the alkyl substituents denote straight and branched chain hydrocarbons of C 1 -C 12 ; loweralkyl denotes alkyl groups of C 1 to C 8 ; alkenyl and alkynyl denote alkyl groups as defined above which are modified so that each contains a carbon to carbon double bond or triple bond, respectively; cycloalkyl denotes rings composed of 5 to 8 methylene groups, each which may be substituted or unsubstituted with other hydrocarbon substituents; benzofused cycloalkyl groups denote a cycloalkyl ring of 5 to 8 carbon atoms to which is fused a benzene ring; bicycloalkyl denotes two cycloalkyl rings of 5 to 8 carbon atoms each joined together in any allowable way; loweralkoxy substituents denote a loweralkyl group as described above attached through an oxygen bridge; the aralkyl and heteroaralkyl substituents denote aryl or heteroaryl groups as herein defined attached through a straight or branched chain hydrocarbon of from one to six carbon atoms; aryl represents phenyl, naphthyl, or biphenyl; heteroaryl represents any 5- or 6-membered aromatic ring containing from one to three heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur as well as any bicyclic group in which any of the above heterocyclic rings is fused to another aromatic ring; and, acylamino represents loweralkanoylamino and aroylamino.
Claim 13
Dependent Claim 639 words
A compound having the formula: ##STR59## and pharmaceutically acceptable salts thereof wherein n is 1; R 4 is hydrogen, lower alkyl, phenyl, phenyl lower alkyl, hydroxy phenyl lower alkyl, hydroxy lower alkyl, amino lower alkyl, acylamino lower alkyl, guanidino lower alkyl, imidazolyl lower alkyl, indolyl lower alkyl, mercapto lower alkyl or lower alkyl thio lower alkyl; R 2 is hydrogen, R 3 is H; halo, lower alkyl, cycloalkyl, or loweralkoxy, R 1 is hydrogen; alkyl of from 1 to 12 carbon atoms which include branched and unsaturated alkyl groups; cycloalkyl; substituted loweralkyl wherein the substituent can be halo, hydroxy, carboxy, carboxamido, loweralkylthio, loweralkoxy, loweralkoxycarbonyl, loweraralkoxycarbonyl, amino, loweralkylamino, lowerdialkylamino, acylamino; substituted loweralkylamino wherein the substituent can be halo, hydroxy, alkoxy or cyano; arloweralkylamino; cyclic amino; oxo, thio or ureido; aryloxy; arylthio; aralkyloxy; aralkylthio; benzofused cycloalkyl or bicycloalkyl of from 8-12 carbon atoms; aryl or heteroaryl which may be mono-, di- or trisubstituted by loweralkyl, hydroxy, loweralkoxy, halo, amino, acylamino, loweralkylthio or aminoloweralkyl; benzofused cycloalkyl or bicycloalkyl of from 8 to 12 carbon atoms; arloweralkyl; arloweralkenyl; heteroloweralkyl and heteroloweralkenyl in which the aryl or heteroaryl rings may be mono-, di- or tri-substituted by halo, loweralkyl, hydroxy, loweralkoxy, amino, loweralkylamino, diloweralkylamino, aminoloweralkyl, acylamino, carboxy, haloloweralkyl, nitro, cyano or sulfonamido; aralkyl or heteroaralkyl which include branched loweralkyl groups; substituted aralkyl or substituted heteroaralkyl which include branched loweralkyl groups wherein the loweralkyl groups can be substituted by amino, acylamino, or hydroxyl and the aryl and heteroaryl groups can be substituted by halo, dihalo, loweralkyl, hydroxy, loweralkoxy, aryloxy, aroyl, arylthio, amino, aminoloweralkyl, loweralkanoylamino, aroylamino, lowerdialkylamino, loweralkylamino, hydroxy, hydroxyloweralkyl, trihaloloweralkyl, nitro, cyano, or sulfonamido; any of the arloweralkyl or alkenyl and heteroloweralkyl or alkenyl groups described above in which the aryl or heteroaryl ring is partially or completely hydrogenated; substituted loweralkyl having the formula R A 1 (CH 2 ) n --Q--(CH 2 ) m wherein n is 0-2, m is 1-3, R A 1 is aryl or heteroaryl optionally substituted by amino, lowerdialkylamino, loweralkylamino, hydroxy, hydroxyloweralkyl, aminoloweralkyl, trihaloloweralkyl, cyano, nitro, sulfonamido, aroyl, loweralkyl, halo, dihalo, and loweralkoxy, and Q is O, S, SO, SO 2 , N-R B 1 , CONR C 1 , NR C 1 CO, CH═CH wherein R B 1 is hydrogen, loweralkyl, aryl, aralkyl, loweralkanoyl, or aroyl, and R C 1 is hydrogen, or loweralkyl; R 5 and R 6 are independently selected from H, lower alkyl, lower alkenyl, diloweralkylamino, loweralkyl, substituted lower alkyl wherein the substituents are monohydroxy, dihydroxy or acylamino; acylloweralkyl and arloweralkyl; and, the pharmaceutically acceptable salts thereof, wherein in said R 1 -R 6 groups, unless stated otherwise, the alkyl substituents denote straight and branched chain hydrocarbons of C 1 -C 12 ; loweralkyl denotes alkyl groups of C 1 to C 8 ; alkenyl and alkynyl denote alkyl groups as defined above which are modified so that each contains a carbon to carbon double bond or triple bond, respectively; cycloalkyl denotes rings composed of 5 to 8 methylene groups, each which may be substituted or unsubstituted with other hydrocarbon substituents; benzofused cycloalkyl groups denote a cycloalkyl ring of 5 to 8 carbon atoms to which is fused a benzene ring; bicycloalkyl denotes two cycloalkyl rings of 5 to 8 carbon atoms each joined together in any allowable way; loweralkoxy substituents denote a loweralkyl group as described above attached through an oxygen bridge; the aralkyl and heteroaralkyl substituents denote aryl or heteroaryl groups as herein defined attached through a straight or branched chain hydrocarbon of from one to six carbon atoms; aryl represents phenyl, naphthyl, or biphenyl; heteroaryl represents any 5- or 6-membered aromatic ring containing from one to three heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur as well as any bicyclic group in which any of the above heterocyclic rings is fused to another aromatic ring; and, acylamino represents loweralkanoylamino and aroylamino.
Claim 14
Dependent Claim 37 words
Compounds of claim 11 wherein: R 1 is loweralkyl, phenyl lower alkyl or amino loweralkyl; R 3 is H; R 4 is H and R 5 and R 6 are independently selected from H lower alkyl arloweralkyl.
Claim 15
Dependent Claim 29 words
Compounds of claim 12 wherein R 1 is phenylloweralkyl and R 5 and R 6 are independently selected from H, CH 3 , C 2 H 5 or benzyl.
Claim 16
Dependent Claim 9 words
Compounds of claim 13 wherein R 1 is ##STR60##
Claim 17
Dependent Claim 22 words
Compounds of claim 14 wherein R 5 is H, CH 3 or benzyl and R 6 is H, CH 3 or ethyl.
Claim 18
Dependent Claim 17 words
Compounds of claim 14 wherein both R 5 and R 6 are H or CH 3 .
Claim 19
Dependent Claim 5 words
A compound which is: 1-carbomethoxymethyl-3-(1-carboethoxy-3-phenyl-1-propyl)aminodihydrocarbostyril.
Claim 20
Dependent Claim 5 words
A compound which is: 1-carbomethoxymethyl-3-(1-carboethoxy-3-phenyl-1-propyl)aminodihydrocarbostyril.
Claim 21
Dependent Claim 5 words
A compound which is: 1-carboxymethyl-3-(1-carboxy-3-phenyl-1-propyl)dihydro-carbostyril.
Claim 22
Dependent Claim 5 words
A compound which is: 1-carboxymethyl-3-(1-carboxy-3-phenyl-1-propyl)dihydro-carbostyril.

References Cited (Backward Citations)

US4410520A Cited
US4470988A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-10-09 1993-04-10 1993-10-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-10-09 1997-04-10 1997-10-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-10-09 2001-04-10 2001-10-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag